Market Cap
₺57.32 Billion
TRY as of Jan. 1, 2026
US$1.33 Billion
| Company | Market Cap (USD) |
|---|---|
Lilly
|
$968.50 B |
Johnson & Johnson
|
$499.57 B |
AbbVie
|
$405.28 B |
Roche
|
$332.12 B |
AstraZeneca
|
$284.38 B |
| Company | Market Cap (USD) |
|---|---|
Lilly
|
$968.50 B |
Johnson & Johnson
|
$499.57 B |
AbbVie
|
$405.28 B |
Roche
|
$332.12 B |
UnitedHealth Group
|
$304.72 B |
Turkey
languages
Healthcare
languages
Drug Manufacturers—General
Turkey Healthcare
Turkey Drug Manufacturers—General
EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. has the following listings and related stock indices.
Stock: BIST: ECILC
The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.